The Polyclonal Antibodies Market is anticipated to experience stable growth, with a projected market size of USD 2.5 billion by 2030. This represents a moderate increase from USD 1.7 billion in 2022, reflecting a Compound Annual Growth Rate (CAGR) of 5.1% over the forecast period (2023-2030). Key Players The major key players are Thermo Fisher Scientific Inc., Merck KGaA, Abcam...